Article -> Article Details
Title | Biologics Safety Testing Market 2023 And Focusing on Top key vendors |
---|---|
Category | Fitness Health --> Addictions |
Meta Keywords | Biologics Safety Testing Market |
Owner | vinit |
Description | |
Biologics Safety Testing Market Analysis Global biologics
safety testing market is predicted to expand at a 13.6%
CAGR between 2018-2023, reveals the new Market Research Future (MRFR)
report. Biological safety testing is conducted to ensure both the
non-contamination and safety of biopharmaceuticals and vaccines and also comply
with its regulations. Bioburden tests, adventitious agent detection tests,
residual host contamination detection tests, cell line authentication &
characterization tests, endotoxin tests, sterility tests, and others are some
major biological tests. It is used in stem cell research, tissue &
tissue-related products testing, cellular & gene therapy, blood &
blood-related products testing, and vaccine & therapeutics development. Numerous factors are adding to the global
biologics safety testing market growth. Such factors, as revealed
by the recent MRFR report, include growing demand for biological products,
growing biotech and pharmaceutical industry, rising number of innovative drug
launches, and high prevalence and huge economic burden of various chronic
diseases. Increasing research and development investment in life science and
favorable government support are also adding market growth. On the contrary, high investment costs related to biological
safety cabinets, time-consuming approval process, stringent government
regulations, and scarcity of skilled professionals to conduct biological safety
testing are factors that may limit the biologics safety testing market growth
during the forecast period. Biologics Safety Testing Market Key Players Leading players profiled in the global biologics safety
testing market report include
Biologics Safety Testing Market Segmentation The Market Research Future Report provides an inclusive
segmental analysis of the biologics safety testing market based on application,
test type, and product. By product, the biologics safety testing market is segmented
into instruments, services, and kits & reagents. Of these, kits and
reagents will lead the market over the forecast period. By test type, the biologics safety testing market is
segmented into bioburden tests, adventitious agent detection tests, residual
host contamination detection tests, cell line authentication &
characterization tests, endotoxin tests, sterility tests, and others. Of these,
endotoxin tests will dominate the market over the forecast period for
increasing drug launches and rising disease prevalence. This testing is used in
drug development, gene therapy, vaccine testing, monoclonal antibody testing,
and cell therapy. By application, the biologics safety testing market has been
segmented into stem cell research, tissue & tissue-related products
testing, cellular & gene therapy, blood & blood-related products
testing, and vaccine & therapeutics development. Of these, vaccine &
therapeutics development will have a major share in the market over the
forecast period for rising company investments to develop vaccines, growing
initiatives for immunization, and increasing prevalence of diseases. Biologics Safety Testing Market Regional Analysis By region, the biologics safety testing market covers
the growth opportunities and recent trends across Europe, the Americas, the
Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the
Americas will command the largest share in the market over the forecast period.
Factors adding to the biologics safety testing market growth in the region
include growing demand for biological products, new product launches, presence
of well-established players, and growing pharmaceutical and biotechnology
industries. Additional factors adding market growth include favorable
government initiatives, rising R&D spending, and advanced healthcare
infrastructure. The global biologics safety testing market in Europe is
predicted to hold the second-largest share during the forecast period for the
growing biotech and pharma industry. The biologics safety testing market in the APAC region is
predicted to grow at a quick pace during the forecast period for the burgeoning
demand for biologics products. The biologics safety testing market in the MEA will have a
small share over the forecast period. The Middle East will have major share for
the presence of a well-established healthcare sector. |